“…LUS demonstrated remarkable sensitivity and negative predictive value (NPV) among reviewed studies, with sensitivity ranging from 68% to 93.3% and a NPV ranging from 52%to 94.1% [78,80,82,87], suggesting the utility of LUS as a screening test to rule out COVID-19 lung infection. Data regarding specificity, positive predictive value (PPV) and diagnostic accuracy has been conflicting, with some studies demonstrating values as low as 21.3%, 19.2% and 33.3% for specificity, PPV and diagnostic accuracy, respectively [87], while others demonstrating higher values up to 92.9%, 84.6% and 93.3% for specificity, PPV and diagnostic accuracy, respectively [78]. Lu W et al demonstrated higher sensitivity and NPV of LUS in patients with moderate disease (77.8% and 88.9%, respectively) with both values reaching 100% in patients with severe disease.…”